Summary Neuroblastoma is the most common extracranial solid tumour of childhood. Amplification of the proto-oncogene, N-myc, confers a poor prognosis in neuroblastoma, while hyperdiploidy is associated with a favourable outcome. Little is known about the contribution of tumour-suppressor genes to the development or progression of neuroblastoma. We examined allelic imbalance at the locus of the tumour-suppressor gene, APC (adenomatous polyposis coli), on chromosome 5q using a polymerase chain reaction (PCR)-based assay. Nine of 24 (37.5%) informative neuroblastoma tumours showed allelic imbalance (Al) at this locus. Clinical data concerning N-myc amplification and DNA content were correlated with these results in the same patients. Allelic imbalance was found only in tumours containing a single copy of the N-myc gene and exhibiting hyperdiploidy. All nine patients with Al of chromosome 5q were alive after a median follow-up period of 46 months, while 7 of 15 (47%) of those lacking Al at this locus had died (P=0.018). Allelic imbalance at three additional loci on chromosome 5 was demonstrated in tumours that exhibited Al at the APC locus, suggesting that endoreduplication of chromosome 5 had occurred. Fluorescent in situ hybridisation (FISH) analysis of tumour tissue from one patient exhibiting AI demonstrated two, three, four or six copies of the APC gene per cell, consistent with this hypothesis. These data suggest that allelic imbalance of chromosome 5 is involved in at least a subset of neuroblastomas and influences survival in patients with neuroblastoma.
Neuroblastoma is the most common extracranial solid tumour of childhood. It originates from primitive neural crest cells that form the sympathetic nervous sysem. Several clinical features of neuroblastoma suggest that discrete biological subgroups of this malignancy exist. Infants less than one year of age generally have a favourable response to therapy, and spontaneous regression is sometimes seen (Evans et al., 1976; MacMillan et al., 1976; Brodeur and Castleberry, 1993) . Conversely, other neuroblastomas behave aggressively, often resulting in death despite surgery, highdose chemoradiotherapy and autologous bone marrow transplantation. Determination of the molecular basis for these disparate clinical outcomes could improve our understanding of neuroblastoma and be valuable in planning therapy.
Several cytogenetic and molecular alterations have been described in neuroblastoma. In 1983, Schwab et al. determined that a gene termed N-myc, related to the protooncogene c-myc, was amplified in many human neuroblastoma cell lines (Schwab et al., 1983) . Subsequent studies have shown that DNA amplification of this gene, found in about 25% of neuroblastomas, is associated with rapid progression of disease (Seeger et al., 1985; Look et al., 1991; Fong et al., 1992) . In one study of neuroblastoma, DNA content, which grossly reflects chromosome number, was diploid (DNA index= 1) in 44%, near-diploid (DNA index 1.18) in 6%, near-triploid (DNA index= 1.25-1.68) in 48% and hypotetraploid (DNA index= 1.85) in 2% of 59 neuroblastoma tumours analysed (Bourhis et al., 1991) . In infants, hyperdiploidy is associated with a favourable outcome.
Conversely, diploidy rarely occurs in localised disease, and it predicts a poor outcome in disseminated disease of infants (Look et al., 1984 (Look et al., , 1991 .
No known tumour-suppressor genes have yet been directly associated with neuroblastoma, but published data suggest that tumour-suppressor gene loci may be important in this cancer. Loss of heterozygosity (LOH) has been demonstrated at chromosome Ip in 25%, at l lq in 42% and at 14q in 23% of neuroblastomas, while LOH was seen in only 5% of neuroblastomas following extensive studies of other loci (Brodeur et al., 1977; Suzuki et al., 1989; Srivatsan et al., 1991; Fong et al., 1992) . Putative tumour-suppressor genes at lp, l lq and 14q have not been identified. LOH at lp is associated with a poor outcome in neuroblastoma, which may be caused at least in part by the observation that LOH of lp frequently occurs in tumours with N-myc amplification (Fong et al., 1989 (Fong et al., , 1992 . It has been reported that the neurofibromatosis type I protein, which has tumoursuppressive properties, was absent in four of ten neuroblastoma cell lines .
A number of tumour-suppressor genes have now been identified in other types of cancer. The most frequently affected tumour-suppressor gene is p53. LOH of 17p, the locus of the p53 gene, was not seen in neuroblastoma (Imamura et al., 1993; Komuro et al., 1993; Vogan et al., 1993) . Another tumour-suppressor gene that has been associated with a variety of cancer types is APC (adenomatous polyposis coli), located on chromosome 5q21. This gene is responsible for the hereditary syndrome, familial adenomatous polyposis (Herrera et al., 1986; Groden et al., 1991; Joslyn et al., 1991; Kinzler et al., 1991; Nishisho et al., 1991) , and is involved by heterozygous deletion or mutation in sporadic colorectal cancers (Miyoshi et al., 1992; Powell et al., 1992) The entire PCR product was digested overnight with 30 units of RsaI in a reaction volume of 60 ,ul. A PCR product that was known to be homozygous for the RsaI site was used to verify complete digestion each time a digestion reaction was performed. The products of digestion were electrophoresed on a 7% native polyacrylamide gel containing 5% glycerol at 150 V for 90 min. The gel was then stained with ethidium bromide, destained and photographed using Polaroid 55 negative/positive film. A laser densitometer (LKB, Bromma, Sweden) and Gel Scan XL computer program (Bromma, Sweden) were used to quantitate bands on the Polaroid negatives. Our data readings were within the linear capabilities of the equipment used.
The data obtained from the laser densitometer was determined to be reproducible by repeated amplification and cleavage of normal DNA from three heterozygotes followed by electrophoresis and multiple scans of the negatives (data not shown). In order to determine the linear range of PCR amplification of the APC fragment, DNA samples were amplified for 24, 26, 28, 30 and 32 cycles as described above. The PCR product reached a plateau between 30 and 32 PCR cycles (data not shown); therefore, 28 cycles were used to maximise PCR product, while remaining in the linear range of amplification.
Theoretically, a mismatch of DNA strands in the final cycle of the PCR reaction could lead to heterodimer formation, that is, annealing of single-stranded DNA containing an RsaI site to single-stranded DNA lacking the site. In the presence of a heterodimer, RsaI would fail to cut despite the presence of the restriction site motif on one DNA strand, thus artifactually increasing the measured uncut allele. We therefore performed in triplicate a mixing experiment in which known amounts of genomic DNA homozygous for the presence or absence of the RsaI site were mixed before PCR amplification. These samples were then analysed as described previously. The results showed that there was no heterodimer formation, since the percentage of cut and uncut alleles after PCR was the same as the percentage of each template added to the PCR reaction (data not shown). These results confirmed those of a similar mixing experiment (Meltzer et al., 1991) .
Normal DNA from patients' blood was PCR amplified, digested, electrophoresed, photographed and scanned using a laser densitometer. Patients whose normal DNA was informative were studied further by comparing their normal and tumour DNA. To determine which tumours showed allelic imbalance, we used a combination of visual inspection of the polyacrylamide gel, analysis of the allele index ratio (described below) and three types of statistical cluster analyses of the data obtained from scanning the gel (SAS Institute, 1989 ). Estimates of survival curves were produced using the method of Kaplan-and Meier (Kaplan and Meier, 1958) . Standard errors of these estimates were obtained by Peto's formula (Peto et al., 1977) . Survival curves were compared using the two-sided log-rank test (Mantel, 1968 Figure 1 . In the these parameters, except for survival, we determined that all two-sided P-values exceeded 0.10 (data not shown). Because of the small sample sizes, we cannot exclude the possibility that these groups actually do differ on some of these characteristics. The status of chromosome lp was unavailable for the majority of patients.
Among the patients exhibiting Al, there were no POG stage D patients (Hayes et al., 1983; Hayes and Smith, 1989) . In contrast, there were four stage D patients among the 15 patients lacking Al, suggesting a possible association between the presence of Al and less severe disease. In fact, all nine patients are alive after a median follow-up period of 46 months, while seven (47%) of those without Al have died. From the Kaplan-Meier lifetime probability curves, threeyear survival of patients without A! of 5q was estimated to be 49% (data not shown). The improved survival associated with Al of 5q was statistically significant (P=0.018).
To determine the background rate of allelic imbalance, we examined the loci of two additional tumour-suppressor genes, p53 on chromosome 17 and DCC (deleted in colorectal cancer) on chromosome 18 (Fearon et al., 1990) (Table II) . DNA from the same 42 patients was amplified by PCR using primers specific for a variable number of tandem repeats (VNTR) within p53 or primers specific for a polymorphic site in the DCC gene, and the products were analysed. For p53, 26 cases were informative, of which three exhibited Al (11.5%). One of them (patient 150) also exhibited Al at the APC locus, one (patient 606) was not informative at APC and the third (patient 701) did not exhibit Al on chromosome 5q. One additional patient (patient 767) exhibited complete loss of one allele, demonstrating that our PCR-based technique can distinguish between LOH and Al. Of the 27 informative cases for the DCC locus, only one (3.7%) exhibited allelic imbalance; this case was not informative at the APC locus.
Since the cells or nuclei from tumours were not sorted or otherwise purified, contamination of tumour tissue with normal tissue may have contributed to the fact that we observed Al rather than LOH. To investigate this possibility, nuclei from tumour tissue of patient 254 were flow cytometrically sorted, then re-examined by PCR after separation of hyperdiploid nuclei from normal, diploid Allelic imbalance in neuroblastoma SJ Meltzer et al x 1859 nuclei. The Al of DNA from hyperdiploid nuclei was unchanged (i.e., still imbalanced) after sorting, while the Al of DNA from the diploid nuclei was in the normal range (data not shown).
In six of the cases exhibiting Al, we examined markers D5S471 (5q23), D5S484 (5q15) and D5S623 (5pl2). Where results were informative, Al was also seen at these loci (data not shown).
Finally, to determine whether the Al we observed resulted from an extra copy of part or all of chromosome 5, FISH was performed on tumour tissue from patient 254, the only patient for whom tissue was available. The probe was a cosmid containing the genomic APC gene. Analysis of this experiment revealed that the cells contained two, three, four or six copies of the APC gene per cell (Figure 3) . Of 200 cells analysed, 43% exhibited two copies, 26% exhibited three copies, 22% exhibited four copies and 9% exhibited six copies per cell. No single chromosome contained more than one copy of the APC gene, suggesting that endoreduplication of part of chromosome 5 had not occurred in this patient. Since all cells contained at least two copies of APC, it is unlikely that a deletion occurred. The presence of three, four or six copies is consistent with hyperdiploidy, although the DNA index for this patient is not known.
Discussion
We have shown that Al involving APC and other loci on chromosome 5 occurs in 37.5% of neuroblastomas. Since Al occurred in only 11.5% of informative cases at the p53 locus and 3.7% of informative cases at the DCC locus in our study, as well as at comparably low rates for other loci in other studies (Brodeur et al., 1977; Suzuki et al., 1989; Srivatsan et al., 1991; Fong et al., 1992) , our data for chromosome 5 are well above background for neuroblastomas. These data imply that the entire chromosome 5 was involved in the allelic imbalance we initially observed at the APC locus. Interestingly, Al on chromosome 5 locus tends to occur in a subset of neuroblastoma tumours in which the N-myc gene is not amplified, the DNA index is greater than 1.00 and survival is excellent.
Although the detection of Al was consistent and reproducible, we did not observe complete loss of one allele. There are several possible explanations for this observation: (1) Contamination of tumour tissue with normal diploid tissue may have occurred, since the nuclei were not sorted. This is unlikely because, in tumour tissue of patient 254, DNA from hyperdiploid nuclei still exhibited the same AIR as the unsorted sample, while DNA from diploid nuclei did not show allelic imbalance; (2) The tumour cell preparations may have included a mixture of some tumour cells retaining and some lacking chromosome 5. This could have been due to polyclonality within the tumour or to the continued progression of neuroblastoma, with Al of chromosome 5 constituting a late event; (3) A likely possibility is that we may have been observing endoreduplication of one homologue of chromosome 5, consistent with the fact that all of the cases exhibiting Al for whom data were available were hyperdiploid. This hypothesis is supported by FISH analysis of tumour tissue from one patient exhibiting Al, in which there were two, three, four, or six copies of the APC gene.
The Al we observed was widespread and involved multiple loci on both arms of chromosome 5, suggesting reduplication of the entire chromosome or large portions of it. Endoreduplication would lead to an apparent increase in either the cut or uncut allele in tumour DNA compared with normal DNA, as we observed. Indeed, an extra chromosome 5 has been noted to occur in several neuroblastoma karyotypes (Kaneko et al., 1987; Hayashi et al., 1989; Look et al., 1991) .
The presence of additional alleles of APC or another gene(s) on chromosome 5 may affect tumorigenesis and tumour behaviour. In other studies, APC copy number was found to influence survival (Shimada and Masayuki, 1994 ). An intriguing possibility in neuroblastoma is that additional wild-type APC alleles present in tumour cells may have suppressed their growth rate and/or tumorigenicity via a dominant negative or 'threshold' effect. Precedent exists for the dominant negative phenomenon in the case of p53, in which introduction of a single copy of the wild-type gene into osteosarcoma cells containing an endogenous mutated p53 gene suppressed the tumorigenicity of these cells and slowed their growth rate (Chen et al., 1990) . Similarly, introduction of one copy of the p53 gene into a human lung carcinoma cell line containing two normal p53 alleles also caused a decreased growth rate and a decreased proportion of Sphase cells (Noble et al., 1992 ). An alternative theory of tumour-suppressor gene inactivation is the 'threshold hypothesis', which holds that a critical amount of the gene product is necessary for proper gene function. This theory is supported by studies of melanoma cells, in which the degree of growth suppression was proportional to the number of copies of chromosome 6 that were introduced into cells (Trent et al., 1990; Robertson et al., 1996) . By analogy, extra copies of chromosome 5 may confer growth-suppressive effects on neuroblastoma cells and an advantage to patients, consistent with the favourable prognosis we observed for 5q allelic imbalance and already associated with hyperdiploidy in neuroblastoma.
